Prediction of long-term survival after liver transplantation for familial transthyretin amyloidosis.

Spanish Ministry of Economy and Competitiveness (grant N BFU 2012-36241) and Programa INNPACTO (grant N IPT-2011-0817-010000) (to Dr. Martin), and from the Agence Nationale de la Recherche (Programme Blanc BCNCT) (to Dr. Lambert). Dr. Alves was a recipient of a PhD grant SFRH/BD/27990/2006 and research grant PTDC/SAU-GMG/101874/2008 from FCT. Mrs. Medeiros was supported by a research grant from the National Institute of Health Doutor Ricardo Jorge (BRJ-DPS/2012). Mr. Benito-Vicente was supported by a grant PIF (2014/2015) Gobierno Vasco. Alirocumab was obtained from Sanofi-Regeneron. Dr. Lambert has received honoraria from Sanofi-Regeneron, Amgen, and Pfizer and research funding from Sanofi-Regeneron. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Drs. Alves and Etxebarria contributed equally to this work.